Research review
Acidophilus benefits: what the research does and doesn't show
The controlled human trials that isolate a single named L. acidophilus strain are few and small, and mostly tested bloating and lactose digestion — not the urinary, vaginal or antibiotic-related uses people search for most.
The evidence doesn't support Lactobacillus acidophilus, as a species, doing any one thing. The controlled human trials that isolate a single named strain are few, small, and mostly measured everyday bloating or lactose digestion — not the urinary, vaginal or antibiotic-related uses people most often search for.
What the evidence doesn't support
It doesn't support taking an oral acidophilus capsule to treat a urinary tract infection, a yeast infection or thrush, bacterial vaginosis, or diarrhea caused by C. difficile — no trial of an oral acidophilus capsule for any of those uses turned up in this review, and one in-vitro study that did test a named strain against C. difficile found no significant effect (below). It also doesn't support treating one strain's results as evidence for another. Products carry a strain code — NCFM, DDS-1, La-14 and others — because closely related strains can differ genetically enough that a finding for one doesn't automatically apply to a different strain, let alone to unnamed "acidophilus" as a category. Every finding below is reported by its exact strain for that reason.
What the trials found
A 2016 randomized, double-blind, placebo-controlled crossover trial gave adults (18–75) who reported lactose intolerance a single daily capsule of the DDS-1 strain of L. acidophilus — 10 billion CFU (1×10¹⁰), taken with food — for 4 weeks, versus placebo for 4 weeks, with a lactose challenge at the end of each period. Of the 22 people who completed both arms, the DDS-1 period showed statistically significant reductions versus placebo in diarrhea, abdominal cramping, vomiting and overall symptom score after the challenge, and no adverse events were reported. It's one of the few trials to test a single L. acidophilus strain alone, at a stated dose, against a placebo.
A 2022 systematic review looked at the full published evidence on probiotics and prebiotics for lactose intolerance and found only three trials of single probiotic strains, covering 117 people combined — the DDS-1 trial above was one of them. It rated the risk of bias a concern in all three probiotic trials and the overall certainty of the probiotic evidence low, and said the strains involved were too different to pool into one estimate. Its conclusion was that DDS-1 and one other unrelated species showed the better results of the three, not that acidophilus in general is established for this use.
A 2011 double-blind, placebo-controlled trial of 60 adults with non-constipation functional bowel disorders (72% women) gave a combination of two strains — L. acidophilus NCFM and Bifidobacterium lactis Bi-07 — at 2×10¹¹ CFU/day divided into two doses, for 8 weeks. Bloating severity improved versus placebo at 4 weeks and 8 weeks. Because this tested two species together, it doesn't isolate what NCFM did on its own — the same research group ran a follow-up to answer that.
That 2014 follow-up gave 20 women with mild-to-moderate abdominal pain either NCFM alone or the NCFM-plus-Bi-07 combination, at 2×10¹⁰ CFU twice daily, for 21 days, and took colon biopsies before and after. NCFM alone — but not the combination — increased a receptor (mu-opioid receptor) in colon tissue that's linked to pain modulation in animal studies. Both groups trended toward symptom improvement, but the authors stated plainly that the trial was "insufficiently powered to draw meaningful conclusions" about whether it actually helped. It's a real, human, single-strain result — just not a proven symptom benefit.
A 2015 laboratory model of the human colon, seeded with human fecal bacteria and infected with C. difficile, tested L. acidophilus NCFM (and a different species, L. paracasei Lpc-37) against the pathogen over two days. C. difficile counts trended down with the lactobacilli but the drop wasn't statistically significant; a fiber ingredient tested in the same model produced the only significant change. This is an in-vitro model, not a human or animal trial, and it found essentially nothing for acidophilus.
| Strain / product | Who | Dose | Duration | Result |
|---|---|---|---|---|
| L. acidophilus DDS-1 | 22 adults, lactose intolerant | 10 billion CFU/day | 4 weeks | Less diarrhea, cramping, vomiting vs. placebo |
| L. acidophilus NCFM + B. lactis Bi-07 | 60 adults, functional bowel disorder | 2×10¹¹ CFU/day | 8 weeks | Less bloating vs. placebo (two-strain combination) |
| L. acidophilus NCFM alone | 20 women, abdominal pain | 4×10¹⁰ CFU/day | 21 days | Receptor change; symptom result inconclusive (underpowered) |
| L. acidophilus NCFM (in-vitro) | Lab colon model | not applicable | 2 days | No significant drop in C. difficile |
Questions people ask
Is acidophilus good for you?
The evidence doesn't support a blanket answer. The trials above tested specific named strains at specific doses for specific outcomes — mostly bloating and lactose digestion — and found mixed, generally small results. It isn't evidence that any acidophilus product does anything for a healthy person with no digestive complaints.
Does acidophilus help a urinary tract infection?
No trial of an oral acidophilus capsule for a urinary tract infection appears in this review. If you have symptoms of one, that's a reason to see a doctor, not to try a supplement instead.
Does acidophilus help bacterial vaginosis?
None of the trials above tested vaginal symptoms, and products marketed for that use are typically applied vaginally rather than swallowed as a capsule — a different route the trials above didn't test either. The evidence doesn't support an oral acidophilus capsule for this.
Does acidophilus help thrush or oral thrush?
No trial above tested candida or thrush. There's no clinical evidence here to support that use.
Does acidophilus help with C. diff?
The only relevant data point above is the in-vitro lab model, and it found no significant reduction in C. difficile from the NCFM strain tested. That's not evidence it works against C. difficile in a person.
Does acidophilus help acid reflux?
None of the trials above measured reflux symptoms. There's nothing in this review to support that use.
Is acidophilus good for dogs or cats?
This review covers human evidence only. A veterinarian is the right person to ask about a pet-specific probiotic.
What are acidophilus's benefits for women specifically?
None of the trials above were designed to test outcomes by sex, though the bloating trial's sample was mostly women (72%) incidentally. That's not the same as a trial testing whether acidophilus does something specific for women's health.
When to talk to a doctor
Persistent or severe digestive symptoms, a suspected urinary or vaginal infection, or diarrhea that starts during or after antibiotics are all reasons to see a doctor rather than try to resolve them with a supplement. Acidophilus is not a treatment for any of those. If you're immunocompromised, critically ill, or have a central line or a heart valve condition, ask a doctor before starting any probiotic — rare but serious infections have been linked to probiotic Lactobacillus strains in those groups, covered in full in acidophilus side effects and who should not take acidophilus.
Sources
- The effects of the DDS-1 strain of lactobacillus on symptomatic relief for lactose intolerance - a randomized, double-blind, placebo-controlled, crossover clinical trial A small crossover trial found the DDS-1 strain of L. acidophilus, at 10 billion CFU a day for 4 weeks, reduced diarrhea, cramping and vomiting during a lactose challenge, with no adverse events.
- The use of probiotics and prebiotics can enable the ingestion of dairy products by lactose intolerant individuals A systematic review found only three human trials of single-strain probiotics for lactose intolerance, rated the evidence low-certainty, and could not pool the strains into one estimate.
- Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study A two-strain combination of L. acidophilus NCFM and B. lactis Bi-07, at a combined 2x10^11 CFU/day for 8 weeks, reduced bloating versus placebo in adults with functional bowel disorders — but this tested two species together, not acidophilus alone.
- Lactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain - a randomised clinical study A small human trial found the NCFM strain of L. acidophilus alone changed a pain-related receptor in colon tissue, but the trial was too small to say whether it actually improved symptoms.
- The effect of polydextrose and probiotic lactobacilli in a Clostridium difficile-infected human colonic model In a lab model of the human colon, the NCFM strain of L. acidophilus did not significantly reduce C. difficile levels.
- Functional genomics of probiotic Lactobacilli Closely related Lactobacillus strains differ enough genetically that a finding for one named strain can't be assumed to apply to a different strain, even within the same species.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.